Clinical Trial: Whole-Plant Cannabis Extracts Associated with Improved Outcomes in Autistic Patients
NORML
FEBRUARY 4, 2021
“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".
Let's personalize your content